About Magle Group
Magle Group is a company based in Malmo (Sweden) founded in 2017. It operates as a B2B. Magle Group offers products and services including Degradable Starch Microspheres (DSM), Dextran Derivatives, and Amniotic-Based Stem Cells. Magle Group operates in a competitive market with competitors including Accubits Invent and IOTA NanoSolutions, among others.
- Headquarter Malmo, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Magle Chemoswed Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magle Group
Magle Group offers a comprehensive portfolio of products and services, including Degradable Starch Microspheres (DSM), Dextran Derivatives, and Amniotic-Based Stem Cells.
Biodegradable particles for oncology and pain management applications.
Versatile materials for drug delivery and tissue engineering.
Stem cells promoting healing in inflammatory diseases.
Funding Insights of Magle Group
Detailed funding history for Magle Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Magle Group
Investment portfolio details for Magle Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Magle Group
Detailed financials for Magle Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Magle Group Comparisons
Peer comparison for Magle Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Magle Group
Magle Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accubits Invent and IOTA NanoSolutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical nanoparticles are provided for industry applications.
|
|
| Locked | Locked | Locked |
Develops biotechnology kits and antibodies for research and detection purposes.
|
Detailed competitors of Magle Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magle Group
Complete news archive for Magle Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magle Group
Magle Group was founded in 2017.
Magle Group is headquartered in Malmo, Sweden.
Magle Group focuses on creating high-quality healthcare innovations through scientific excellence, including degradable starch microspheres, dextran derivatives, and amniotic-based stem cells. They operate as a contract development and manufacturing organization, serving pharmaceutical and medical device companies by streamlining product development and reducing costs. Based in Sweden and Denmark, with a sales network in Germany, they prioritize patient-centric solutions that enhance outcomes and address unmet medical needs, fostering growth through partnerships.
Magle Group's top competitors include Accubits Invent and IOTA NanoSolutions.
Magle Group offers Degradable Starch Microspheres (DSM), Dextran Derivatives, and Amniotic-Based Stem Cells.